… II trials of paclitaxel and … therapy in HRPC, highlights ongoing trials, and discusses future
prospects for building on the encouraging results of antimicrotubule therapy of prostate cancer…

… of paclitaxel resistance in prostate cancer. Ectopic expression of CD133 in prostate cancer
leads to … in the delivery of paclitaxel in prostate cancer to potentiate its anti-tumor capacity. …

… These data indicate that this magnetically targeted drug delivery system provides more
effective treatment of prostate cancer cells using lower therapeutic doses and thus with …

… This study shows that weekly paclitaxel (100 mg/m 2 ) can be administered safely in … prostate
cancer. Pharmacokinetic analysis revealed a linear increase in the AUC of paclitaxel as the …

… main therapeutic option of advanced prostate cancer (PCa) is androgen deprivation
therapy … Androgen-sensitive prostate cancer LNCaP cells were found to be more resistant to …

… In this study, we combined quercetin and paclitaxel to kill prostate cancer cells in vivo and
in … After the cancer cells were treated with quercetin or/and paclitaxel, cell growth inhibition, …

… Several groups of researches have studied whether the sensitivity to docetaxel and paclitaxel
could be altered by miRNAs in prostate cancer cells. The development of chemoresistance …

… Prostate cancer (PCa) is the most prevalent cancer among men in … remains the second-leading
cause of cancer mortality in men. … Prostate cancer (PCa) is the most prevalent cancer and …

… paclitaxel is used for hormone-resistant prostate cancer, relapse definitely occurs later.
Details of the molecular mechanism responsible for paclitaxel… We established paclitaxel-resistant …

… with taxane (paclitaxel or docetaxel) against human prostate cancer cells using single doses.
… a novel therapeutic strategy for the treatment of prostate cancer with a prostate cancer-…